BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17573692)

  • 1. Treatment of resistant pure red cell aplasia after major ABO-incompatible bone marrow transplantation with human adipose tissue-derived mesenchymal stem cells.
    Fang B; Song Y; Zhao RC; Han Q; Cao Y
    Am J Hematol; 2007 Aug; 82(8):772-3. PubMed ID: 17573692
    [No Abstract]   [Full Text] [Related]  

  • 2. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.
    Labar B; Bogdanić V; Nemet D; Kovacević-Metelko J; Mrsić M; Pavletić Z; Zupancić-Salek S; Radman I; Aurer I
    Bone Marrow Transplant; 1992 Nov; 10(5):471-2. PubMed ID: 1464014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.
    Fang B; Song Y; Li N; Li J; Han Q; Zhao RC
    Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
    Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
    Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.
    Ohashi K; Akiyama H; Takamoto S; Tanikawa S; Sakamaki H; Onozawa Y
    Bone Marrow Transplant; 1994 Mar; 13(3):335-6. PubMed ID: 8199576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
    Huang T; Sun J; Liu J; Liu QF; Men FY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
    Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
    Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with bolus methylprednisolone for pure red cell aplasia after ABO incompatible bone marrow transplantation in a patient with chronic myelocytic leukemia].
    Furuya H; Wakayama T; Tanaka J; Tsumori M; Hatazoe T; Ohguni S; Sato T; Ishikura H; Kato Y
    Rinsho Ketsueki; 1995 Nov; 36(11):1279-83. PubMed ID: 8691568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
    Hayden PJ; Gardiner N; Molloy K; Ryan J; Lawler M; McCann SR
    Bone Marrow Transplant; 2004 Feb; 33(4):459-61. PubMed ID: 14676777
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistant pure red cell aplasia after allogeneic bone marrow transplantation with major ABO mismatch treated by purified CD34+ cell infusion.
    Woo HY; Min CK; Lee SM; Cho HS; Kim SY; Lee S; Lee JW; Min WS; Kim CC; Kim Y
    Eur J Haematol; 2006 Feb; 76(2):160-3. PubMed ID: 16405438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.
    Verholen F; Stalder M; Helg C; Chalandon Y
    Eur J Haematol; 2004 Dec; 73(6):441-6. PubMed ID: 15522068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
    Rabitsch W; Knöbl P; Prinz E; Keil F; Greinix H; Kalhs P; Worel N; Jansen M; Hörl WH; Derfler K
    Bone Marrow Transplant; 2003 Nov; 32(10):1015-9. PubMed ID: 14595389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.
    Yamaguchi M; Sakai K; Murata R; Ueda M
    Bone Marrow Transplant; 2002 Oct; 30(8):539-41. PubMed ID: 12379896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors.
    Hirokawa M; Fukuda T; Ohashi K; Hidaka M; Ichinohe T; Iwato K; Kanamori H; Murata M; Sakura T; Imamura M; Adachi S; Suzuki R; Morishima Y; Sakamaki H;
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1026-32. PubMed ID: 23583828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation.
    Selleri C; Raiola A; De Rosa G; Luciano L; Pezzullo L; Picardi M; Rotoli B
    Bone Marrow Transplant; 1998 Sep; 22(6):605-7. PubMed ID: 9758354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.
    Maschan AA; Skorobogatova EV; Balashov DN; Pashanov ED; Trakhtman PE; Schipitzina IP; Skvortsova YV; Rumiantzev AG
    Bone Marrow Transplant; 2002 Sep; 30(6):405-7. PubMed ID: 12235527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation].
    Huang XJ; Liu DH; Xu LP; Han W; Jiang Q; Chen YH; Zhang YC; Liu KY; Bao L; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):548-50. PubMed ID: 16468333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.